Precipio ROE 2011-2025 | PRPO
Current and historical return on equity (ROE) values for Precipio (PRPO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Precipio ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-09-30 | $0.00B | $0.01B | -8.00% |
| 2025-06-30 | $0.00B | $0.01B | -16.67% |
| 2025-03-31 | $0.00B | $0.01B | -25.00% |
| 2024-12-31 | $0.00B | $0.01B | -32.65% |
| 2024-09-30 | $0.00B | $0.01B | -23.53% |
| 2024-06-30 | $0.00B | $0.01B | -23.08% |
| 2024-03-31 | $0.00B | $0.01B | -29.63% |
| 2023-12-31 | $-0.01B | $0.01B | -36.36% |
| 2023-09-30 | $-0.01B | $0.01B | -56.14% |
| 2023-06-30 | $-0.01B | $0.01B | -64.52% |
| 2023-03-31 | $-0.01B | $0.01B | -57.97% |
| 2022-12-31 | $-0.01B | $0.02B | -62.34% |
| 2022-09-30 | $-0.01B | $0.02B | -55.81% |
| 2022-06-30 | $-0.01B | $0.02B | -46.81% |
| 2022-03-31 | $-0.01B | $0.02B | -48.00% |
| 2021-12-31 | $-0.01B | $0.03B | -34.41% |
| 2021-09-30 | $-0.01B | $0.03B | -39.02% |
| 2021-06-30 | $-0.01B | $0.03B | -51.43% |
| 2021-03-31 | $-0.01B | $0.02B | -57.14% |
| 2020-12-31 | $-0.01B | $0.01B | -107.69% |
| 2020-09-30 | $-0.02B | $0.01B | -125.49% |
| 2020-06-30 | $-0.02B | $0.01B | -115.38% |
| 2020-03-31 | $-0.02B | $0.01B | -143.40% |
| 2019-12-31 | $-0.01B | $0.01B | -107.69% |
| 2019-09-30 | $-0.02B | $0.02B | -151.11% |
| 2019-06-30 | $-0.02B | $0.01B | -194.87% |
| 2019-03-31 | $-0.02B | $0.01B | -172.97% |
| 2018-12-31 | $-0.02B | $0.01B | -200.00% |
| 2018-09-30 | $-0.03B | $0.01B | -221.28% |
| 2018-06-30 | $-0.03B | $0.01B | -220.69% |
| 2018-03-31 | $-0.04B | $0.01B | -230.30% |
| 2017-12-31 | $-0.03B | $0.01B | -412.50% |
| 2017-09-30 | $-0.02B | $0.02B | -584.62% |
| 2017-06-30 | $-0.01B | $0.02B | 144.00% |
| 2017-03-31 | $0.00B | $-0.02B | 0.00% |
| 2016-12-31 | $0.00B | $-0.01B | 21.82% |
| 2016-09-30 | $-0.02B | $-0.02B | 154.84% |
| 2016-06-30 | $-0.03B | $-0.02B | 345.95% |
| 2016-03-31 | $-0.04B | $-0.02B | 1400.00% |
| 2015-12-31 | $-0.03B | $-0.01B | -906.67% |
| 2015-09-30 | $-0.02B | $0.01B | -228.57% |
| 2015-06-30 | $-0.01B | $0.01B | -126.32% |
| 2015-03-31 | $-0.01B | $0.01B | -140.54% |
| 2014-12-31 | $-0.01B | $0.01B | -136.59% |
| 2014-09-30 | $-0.01B | $0.01B | -106.67% |
| 2014-06-30 | $-0.02B | $0.01B | -144.00% |
| 2014-03-31 | $-0.02B | $0.01B | -111.48% |
| 2013-12-31 | $-0.02B | $0.01B | -95.77% |
| 2013-09-30 | $-0.02B | $0.02B | -75.00% |
| 2013-06-30 | $-0.01B | $0.02B | -54.55% |
| 2013-03-31 | $-0.01B | $0.02B | -43.48% |
| 2012-12-31 | $-0.01B | $0.02B | -38.30% |
| 2012-09-30 | $-0.01B | $0.02B | -32.94% |
| 2012-06-30 | $-0.01B | $0.03B | -40.00% |
| 2012-03-31 | $-0.01B | $0.03B | -125.71% |
| 2011-12-31 | $-0.01B | $0.01B | -293.33% |
| 2011-09-30 | $-0.01B | $0.00B | -369.23% |
| 2011-06-30 | $-0.01B | $0.00B | -183.33% |
| 2011-03-31 | $-0.01B | $0.01B | -70.59% |
| 2010-12-31 | $0.00B | $0.01B | -30.77% |
| 2010-09-30 | $0.00B | $0.01B | -19.05% |
| 2010-06-30 | $0.00B | $0.01B | -9.09% |
| 2010-03-31 | $0.00B | $0.01B | -8.70% |
| 2009-12-31 | $0.00B | $0.01B | -17.02% |
| 2009-09-30 | $0.00B | $0.01B | -16.67% |
| 2009-06-30 | $0.00B | $0.01B | -15.69% |
| 2009-03-31 | $0.00B | $0.01B | -7.55% |
| 2008-12-31 | $0.00B | $0.01B | 0.00% |
| 2008-09-30 | $0.00B | $0.01B | 0.00% |
| 2008-06-30 | $0.00B | $0.01B | -7.14% |
| 2008-03-31 | $0.00B | $0.01B | -7.02% |
| 2007-12-31 | $0.00B | $0.01B | -13.79% |
| 2007-09-30 | $0.00B | $0.01B | -20.00% |
| 2007-06-30 | $0.00B | $0.02B | -25.40% |
| 2007-03-31 | $0.00B | $0.02B | -24.24% |
| 2006-12-31 | $0.00B | $0.02B | -17.39% |
| 2006-09-30 | $-0.01B | $0.02B | -73.24% |
| 2006-06-30 | $-0.01B | $0.02B | -62.86% |
| 2006-03-31 | $-0.01B | $0.02B | -70.59% |
| 2005-12-31 | $-0.02B | $0.02B | -89.55% |
| 2005-09-30 | $-0.01B | $0.02B | -66.67% |
| 2005-06-30 | $-0.02B | $0.02B | -107.04% |
| 2005-03-31 | $-0.03B | $0.02B | -157.14% |
| 2004-12-31 | $-0.03B | $0.02B | -121.43% |
| 2004-09-30 | $-0.04B | $0.02B | -100.00% |
| 2004-06-30 | $-0.03B | $0.03B | -78.57% |
| 2004-03-31 | $-0.02B | $0.05B | -47.67% |
| 2003-12-31 | $-0.02B | $0.05B | -44.88% |
| 2003-09-30 | $-0.02B | $0.05B | -43.24% |
| 2003-06-30 | $-0.02B | $0.05B | -37.70% |
| 2003-03-31 | $-0.02B | $0.06B | -33.21% |
| 2002-12-31 | $-0.02B | $0.06B | -29.27% |
| 2002-09-30 | $-0.02B | $0.07B | -19.54% |
| 2002-06-30 | $-0.01B | $0.08B | -15.05% |
| 2002-03-31 | $-0.01B | $0.08B | -12.16% |
| 2001-12-31 | $-0.01B | $0.08B | -9.91% |
| 2001-09-30 | $-0.01B | $0.08B | -6.35% |
| 2001-06-30 | $-0.01B | $0.09B | -6.47% |
| 2001-03-31 | $-0.01B | $0.07B | -11.06% |
| 2000-12-31 | $-0.01B | $0.07B | -23.02% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.037B | $0.019B |
| Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.404B | 55.40 |
| Tempus AI (TEM) | United States | $11.811B | 0.00 |
| Doximity (DOCS) | United States | $8.862B | 36.49 |
| Hims & Hers Health (HIMS) | United States | $8.100B | 65.89 |
| IRhythm Technologies (IRTC) | United States | $5.397B | 0.00 |
| Hinge Health (HNGE) | United States | $3.215B | 0.00 |
| Privia Health (PRVA) | United States | $2.856B | 178.62 |
| Inspire Medical Systems (INSP) | United States | $2.466B | 40.80 |
| Heartflow (HTFL) | United States | $2.248B | 0.00 |
| 10x Genomics (TXG) | United States | $1.987B | 0.00 |
| Enovis (ENOV) | United States | $1.618B | 8.50 |
| Omnicell (OMCL) | United States | $1.534B | 31.37 |
| Azenta (AZTA) | United States | $1.346B | 58.74 |
| Schrodinger (SDGR) | United States | $1.286B | 0.00 |
| Phreesia (PHR) | United States | $1.234B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.214B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.891B | 0.00 |
| Claritev (CTEV) | United States | $0.630B | 0.00 |
| Talkspace (TALK) | United States | $0.527B | 106.00 |
| Veradigm (MDRX) | United States | $0.517B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.498B | 0.00 |
| Standard BioTools (LAB) | United States | $0.465B | 0.00 |
| Evolent Health (EVH) | United States | $0.432B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.348B | 0.00 |
| Carlsmed (CARL) | United States | $0.327B | 0.00 |
| TruBridge (TBRG) | United States | $0.308B | 14.15 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.274B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.256B | 0.00 |
| CapsoVision (CV) | United States | $0.248B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.208B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.192B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.162B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.158B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.152B | 0.00 |
| CareCloud (CCLD) | United States | $0.132B | 7.23 |
| EUDA Health Holdings (EUDA) | Singapore | $0.103B | 0.00 |
| Outset Medical (OM) | United States | $0.089B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.073B | 0.00 |
| American Well (AMWL) | United States | $0.065B | 0.00 |
| Pulmonx (LUNG) | United States | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.043B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.043B | 0.00 |
| 111 (YI) | China | $0.034B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.024B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.021B | 0.00 |
| Zhongchao (ZCMD) | China | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.014B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |